Your Article SummaryDivalproex extended-release in acute bipolar II depression (>> click to go to the journal's website)Journal of Affective Disorders, 06/02/10 |
Wang PW et al. – Divalproex–ER as monotherapy and adjunctive therapy was well tolerated and yielded an overall response rate of 54% in bipolar II depression.
Based on the results of this pilot study, randomized, double–blind, placebo–controlled studies of divalproex–ER in bipolar II depression are warranted.Receive more summaries like this by joining MDLinx. We provide free daily digests of top journal articles in your field. >> Click here to choose your specialties. |
Other articles in Psychiatry>> Click here to see the complete listGenetic and
environmental influences on focal brain density in bipolar disorder Bipolar disorder and
metabolic syndrome: An international perspective Impairment of verbal
learning and memory and executive function in unaffected siblings of probands with bipolar disorder |
Your Article SummaryHyperprolactinemia associated with psychotropics - a review (>> click to go to the journal's website)Human Psychopharmacology: Clinical and Experimental, 05/10/10 |
Madhusoodanan S et al. – Clinicians need to be alert about the potential for hyperprolactinemia and its manifestations with these medications. Prolactin levels need to
be monitored and other causes of hyperprolactinemia ruled out in suspected cases.Receive more summaries like this by joining MDLinx. We provide free daily digests of top journal articles in your field. >> Click here to choose your specialties. |
Other articles in Psychiatry>> Click here to see the complete listRisperidone-Induced
Bulbar Palsy-like Syndrome Galactorrhea After
Aesthetic Breast Augmentation With Silicone Implants: Report of Two Cases and Management of Postoperative Galactorrhea High levels of serum
prolactin protect against diabetic retinopathy by increasing ocular vasoinhibins |
Questionable Antipsychotic Prescribing Remains Common, Despite Serious Risks (>> click to go to the journal's
website) JAMA, 04/28/10 |
Kuehn BM – Despite their association with serious cardiac and metabolic risks, atypical antipsychotics are widely used off–label with few data to support their
efficacy, according to recent studies probing use of this class of drugs in the United States. Furthermore, physicians often do not follow through on precautions to reduce these
risks.Receive more summaries like this by joining MDLinx. We provide free daily digests of top journal articles in your field. >> Click here to choose your specialties. |
Other articles in Psychiatry>> Click here to see the complete listTreatment with
antipsychotics and the risk of diabetes in clinical practice Risk of Falls and
Fractures in Older Adults Using Antipsychotic Agents: A Propensity-Matched Retrospective Cohort Study Predictors of switching
antipsychotic medications in the treatment of schizophrenia |
Your Article SummaryThe Role of Ondansetron in the Treatment of Schizophrenia (>> click to go to the journal's website)Annals of Pharmacotherapy, 06/04/10 |
Bennett AC et al. – Ondansetron may be effective as an adjunct to antipsychotics for the treatment of schizophrenia, specifically negative symptoms, as assessed with
PANSS. Due to the variation in concurrent therapies and dosing regimens, it is difficult to establish an optimal dose from the reviewed trials. Further large, randomized,
double–blind, active–controlled studies would be helpful in determining the role of ondansetron in the treatment of schizophrenia.Receive more summaries like this by joining MDLinx. We provide free daily digests of top journal articles in your field. >> Click here to choose your specialties. |
Other articles in Psychiatry>> Click here to see the complete listExamining the course
and outcome of individuals diagnosed with schizophrenia and comorbid borderline personality disorder Analysis of HapMap
tag-SNPs in dysbindin (DTNBP1) reveals evidence of consistent association with schizophrenia Suicidal attempts and
increased right amygdala volume in schizophrenia |
Your Article SummaryTreatment with antipsychotics and the risk of diabetes in clinical practice (>> click to go to the journal's website)British Journal of Psychiatry, 10/06/10 |
Kessing LV et al. ? The objective of this study was to investigate and characterise the incidence of diabetes for people treated with antipsychotic medication in clinical
practice. In clinical practice, treatment with first- and second-generation antipsychotics is associated with an increased risk of developing incident diabetes with large differences
between individual drugs. The risk increases with the duration of treatment and with polypharmacy of antipsychotic drugs. Methods
Receive more summaries like this by joining MDLinx. We provide free daily digests of top journal articles in your field. >> Click here to choose your specialties. |
Other articles in Psychiatry>> Click here to see the complete listDiscovery of novel
allosteric modulators of metabotropic glutamate receptor subtype 5 reveals chemical and functional diversity and in vivo activity in model behavioral models of anxiolytic and antipsychotic
activity Psychotropic medication
use mediates the relationship between mood and anxiety disorders and obesity: Findings from a nationally representative sample Risk of Hospitalization
for Stroke Associated with Antipsychotic Use in the Elderly: A Self-Controlled Case Series |
No comments:
Post a Comment